Roanna Ruiz
Stock Analyst at Leerink Partners
(2.59)
# 2,832
Out of 4,453 analysts
445
Total ratings
47.9%
Success rate
1%
Average return
Main Sectors:
Stocks Rated by Roanna Ruiz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UTHR United Therapeutics | Reiterated: Buy | $615 → $700 | $543.39 | +28.82% | 25 | Jun 12, 2026 | |
| VIR Vir Biotechnology | Reiterated: Buy | n/a | $9.88 | - | 33 | May 27, 2026 | |
| CRMD CorMedix | Reiterated: Buy | $13 → $15 | $7.72 | +94.30% | 11 | May 15, 2026 | |
| IBIO iBio, Inc. | Maintained: Buy | $5 → $6 | $1.59 | +277.36% | 3 | May 15, 2026 | |
| AQST Aquestive Therapeutics | Reiterated: Buy | $9 | $4.47 | +101.57% | 24 | May 15, 2026 | |
| MNKD MannKind | Maintained: Buy | n/a | $3.93 | - | 1 | Feb 25, 2026 | |
| CYTK Cytokinetics | Reiterated: Buy | n/a | $80.80 | - | 30 | Jan 13, 2026 | |
| TRVI Trevi Therapeutics | Reiterated: Buy | $16 | $18.00 | -11.11% | 1 | Nov 18, 2025 | |
| ENTA Enanta Pharmaceuticals | Maintained: Hold | $7 → $9 | $13.45 | -33.09% | 37 | Oct 1, 2025 | |
| HKG: 2137 Brii Biosciences Limited | Reiterated: Hold | $1.00 → $2.00 | $0.98 | +104.08% | 8 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $1.04 | +573.08% | 6 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $99 | $109.01 | -9.18% | 53 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $7.40 | +21.62% | 35 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $8.02 | +249.13% | 27 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $2.29 | -56.33% | 17 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $107 → $44 | $31.73 | +38.67% | 27 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $11 | $6.06 | +81.52% | 11 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 | $16.35 | -38.84% | 30 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $135.51 | n/a | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 → $4 | $4.35 | n/a | 23 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 | $5.50 | n/a | 22 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $23 | $84.75 | n/a | 6 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $80 | $0.000001 | n/a | 13 | Dec 20, 2022 |
United Therapeutics
Jun 12, 2026
Reiterated: Buy
Price Target: $615 → $700
Current: $543.39
Upside: +28.82%
Vir Biotechnology
May 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $9.88
Upside: -
CorMedix
May 15, 2026
Reiterated: Buy
Price Target: $13 → $15
Current: $7.72
Upside: +94.30%
iBio, Inc.
May 15, 2026
Maintained: Buy
Price Target: $5 → $6
Current: $1.59
Upside: +277.36%
Aquestive Therapeutics
May 15, 2026
Reiterated: Buy
Price Target: $9
Current: $4.47
Upside: +101.57%
MannKind
Feb 25, 2026
Maintained: Buy
Price Target: n/a
Current: $3.93
Upside: -
Cytokinetics
Jan 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $80.80
Upside: -
Trevi Therapeutics
Nov 18, 2025
Reiterated: Buy
Price Target: $16
Current: $18.00
Upside: -11.11%
Enanta Pharmaceuticals
Oct 1, 2025
Maintained: Hold
Price Target: $7 → $9
Current: $13.45
Upside: -33.09%
Brii Biosciences Limited
Aug 25, 2025
Reiterated: Hold
Price Target: $1.00 → $2.00
Current: $0.98
Upside: +104.08%
Aug 22, 2025
Reiterated: Buy
Price Target: $7
Current: $1.04
Upside: +573.08%
Aug 22, 2025
Maintained: Buy
Price Target: $99
Current: $109.01
Upside: -9.18%
Aug 20, 2025
Reiterated: Buy
Price Target: $9
Current: $7.40
Upside: +21.62%
Aug 14, 2025
Reiterated: Buy
Price Target: $28
Current: $8.02
Upside: +249.13%
Aug 7, 2025
Reiterated: Hold
Price Target: $1
Current: $2.29
Upside: -56.33%
Aug 7, 2025
Reiterated: Buy
Price Target: $107 → $44
Current: $31.73
Upside: +38.67%
Aug 5, 2025
Reiterated: Buy
Price Target: $10 → $11
Current: $6.06
Upside: +81.52%
Jul 31, 2025
Reiterated: Hold
Price Target: $10
Current: $16.35
Upside: -38.84%
Mar 6, 2025
Maintained: Buy
Price Target: n/a
Current: $135.51
Upside: n/a
May 14, 2024
Maintained: Hold
Price Target: $5 → $4
Current: $4.35
Upside: n/a
May 7, 2024
Maintained: Hold
Price Target: $25
Current: $5.50
Upside: n/a
Jan 22, 2024
Maintained: Hold
Price Target: $23
Current: $84.75
Upside: n/a
Dec 20, 2022
Reiterated: Hold
Price Target: $80
Current: $0.000001
Upside: n/a